ArticleProceedings (Baylor University. Medical Center)2025

Fezolinetant for vasomotor symptoms in postmenopausal women.

Belinda M Kohl-Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.